RENOVORX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations
RENOVORX, INC. (RNXT) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations of 3.96 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations · last filed 2026-08-13
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2025-12-31 was 90.00K shares.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2025-09-30 was 67.50K shares.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2025-06-30 was 0.00 shares.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2025-03-31 was 9.00K shares.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2025 was 166.50K shares, a 825.00% increase from fiscal 2024.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2024 was 18.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 12 month |
|---|---|---|---|---|
| 2026-06-30 | 3.96M shares 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | 90.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 157.50K shares derived: sum of 2 quarters · filed 2026-03-30 | 157.50K shares derived: sum of 3 quarters · filed 2026-03-30 | 166.50K shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 67.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 67.50K shares derived: sum of 2 quarters · filed 2025-11-13 | 76.50K shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 9.00K shares 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | 9.00K shares 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | 18.00K shares 10-K · filed 2025-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |